BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

514 related articles for article (PubMed ID: 19817550)

  • 21. Unmasking of epigenetically silenced candidate tumor suppressor genes by removal of methyl-CpG-binding domain proteins.
    Lopez-Serra L; Ballestar E; Ropero S; Setien F; Billard LM; Fraga MF; Lopez-Nieva P; Alaminos M; Guerrero D; Dante R; Esteller M
    Oncogene; 2008 Jun; 27(25):3556-66. PubMed ID: 18223687
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Epigenetic gene regulation in cancer.
    Ballestar E; Esteller M
    Adv Genet; 2008; 61():247-67. PubMed ID: 18282509
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Promoter hypermethylation of multiple genes in early gastric adenocarcinoma and precancerous lesions.
    Zou XP; Zhang B; Zhang XQ; Chen M; Cao J; Liu WJ
    Hum Pathol; 2009 Nov; 40(11):1534-42. PubMed ID: 19695681
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The role of epigenetic alterations in pancreatic cancer.
    Sato N; Goggins M
    J Hepatobiliary Pancreat Surg; 2006; 13(4):286-95. PubMed ID: 16858539
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Epigenetic regulation: a new research area for melatonin?
    Korkmaz A; Reiter RJ
    J Pineal Res; 2008 Jan; 44(1):41-4. PubMed ID: 18078446
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Epigenetic processes in malignant transformation: the role of DNA methylation in cancer development].
    Suijkerbuijk KP; van der Wall E; van Laar T; Vooijs M; van Diest PJ
    Ned Tijdschr Geneeskd; 2007 Apr; 151(16):907-13. PubMed ID: 17500342
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Aberrant gene silencing in tumor progression: implications for control of cancer.
    Baylin SB; Chen WY
    Cold Spring Harb Symp Quant Biol; 2005; 70():427-33. PubMed ID: 16869780
    [TBL] [Abstract][Full Text] [Related]  

  • 28. CpG islands: their potential as biomarkers for cancer.
    Shi H; Wang MX; Caldwell CW
    Expert Rev Mol Diagn; 2007 Sep; 7(5):519-31. PubMed ID: 17892361
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Genomic patterns of DNA methylation: targets and function of an epigenetic mark.
    Weber M; Schübeler D
    Curr Opin Cell Biol; 2007 Jun; 19(3):273-80. PubMed ID: 17466503
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Epigenetic regulation and colorectal cancer.
    Matsubara N
    Dis Colon Rectum; 2012 Jan; 55(1):96-104. PubMed ID: 22156874
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Role of epigenetic DNA alterations in the pathogenesis of systemic lupus erythematosus.
    Januchowski R; Prokop J; Jagodziński PP
    J Appl Genet; 2004; 45(2):237-48. PubMed ID: 15131354
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Epigenetic targets in cancer epidemiology.
    Dumitrescu RG
    Methods Mol Biol; 2009; 471():457-67. PubMed ID: 19109794
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Novel methylation and expression markers associated with breast cancer].
    Kuznetsova EB; Kekeeva TV; Larin SS; Zemliakova VV; Babenko OV; Nemtsova MV; Zaletaev DV; Strel'nikov VV
    Mol Biol (Mosk); 2007; 41(4):624-33. PubMed ID: 17936981
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Colorectal cancer epigenetics: the role of environmental factors and the search for molecular biomarkers.
    Ahmed FE
    J Environ Sci Health C Environ Carcinog Ecotoxicol Rev; 2007; 25(2):101-54. PubMed ID: 17558783
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Recursive causality in evolution: a model for epigenetic mechanisms in cancer development.
    Haslberger A; Varga F; Karlic H
    Med Hypotheses; 2006; 67(6):1448-54. PubMed ID: 16844314
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Role and significance of DNA methylation].
    Kowal M; Wojcierowski J
    Pol Merkur Lekarski; 2003 Apr; 14(82):364-8. PubMed ID: 12868204
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Alterations of DNA methylation and clinicopathological diversity of human cancers.
    Kanai Y
    Pathol Int; 2008 Sep; 58(9):544-58. PubMed ID: 18801069
    [TBL] [Abstract][Full Text] [Related]  

  • 38. DNA methyltransferase inhibitors and the development of epigenetic cancer therapies.
    Lyko F; Brown R
    J Natl Cancer Inst; 2005 Oct; 97(20):1498-506. PubMed ID: 16234563
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Role of epigenetic changes in hematological malignancies.
    Lehmann U; Brakensiek K; Kreipe H
    Ann Hematol; 2004 Mar; 83(3):137-52. PubMed ID: 15064862
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Role of hypermethylation on carcinogenesis in the pancreas.
    Kuroki T; Tajima Y; Kanematsu T
    Surg Today; 2004; 34(12):981-6. PubMed ID: 15580378
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 26.